Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem Cells for Liver Cirrhosis
NCT01877759Phase 2Unknown
- Sponsor
- Chaitanya Hospital
- Start
- Dec 2013
- Primary completion
- Dec 2014
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous bone marrow-derived stem cells and human umbilical cord derived mesenchymal stem cells in Liver cirrhosis (LC), sponsored by Chaitanya Hospital. Primary endpoint: Liver Function Tests at 6 months. Status: unknown.
02
Drugs
autologous bone marrow-derived stem cellshuman umbilical cord derived mesenchymal stem cells
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT01877759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01877759.